InvestorsHub Logo
Followers 34
Posts 808
Boards Moderated 0
Alias Born 12/03/2014

Re: Axxxe post# 66441

Friday, 03/03/2017 12:59:14 PM

Friday, March 03, 2017 12:59:14 PM

Post# of 84943
IBOX has EVERYTHING.

Cherry Picking:

Acnease, the flagship product:
Herbal acne prevention product. NOT a topical symptom treating solution such as proactive. Acnease is designed to stop future outbreaks before they occur. Comparable products in the acne prevention category are Acutane and birth control pills. While Acutane is 90% effective there are severe adverse side effects and there are plenty of lawsuit commercials on TV attempting to represent those affected. People who take Acutane regularly go through blood testing to monitor liver enzyme levels and if levels are too high they must stop Accutane or face liver disease. On the other hand, Acnease is 96% effective and completely natural and therefore has no side effects; Acnease is head and shoulders above the competition.


2016 was first profitable year for the company (done w/o selling a single share)

HBRM made a big push in international markets in 2016 especially in France and UK where sales DOUBLED.

2016 Herborium's Revenue increased by 18.3 %

2016 Gross Profit increased by 16.3%

The Company's Acne blog was ranked on "The Best Skincare Blogs of 2016" by Healthline for the SECOND CONSECUTIVE YEAR.

Featured in Cosmopolitan Magazine twice as a top beauty editor pick for acne treatment



2017 expectation of over a million in sales to HUT Group

2017 expectation of expanded product pipeline and increased market penetration in both retail and wholesale sectors.


All in all, HBRM is PROFITABLE, POPULAR and EXPANDING.
The pps as of now, is par value and can only go up. The company has NOT SOLD A SHARE IN OVER A YEAR. Everything is coming together quickly for this company and its current shareholders.
2017 will be BIG